LPL Financial’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
84,415
+70
+0.1% +$249 ﹤0.01% 5586
2026
Q1
$267K Sell
84,345
-447
-0.5% -$1.71K ﹤0.01% 5274
2025
Q4
$410K Sell
84,792
-355
-0.4% -$1.48K ﹤0.01% 4903
2025
Q3
$243K Sell
85,147
-515
-0.6% -$1.33K ﹤0.01% 5210
2025
Q2
$131K Buy
85,662
+915
+1% +$1.32K ﹤0.01% 5211
2025
Q1
$105K Sell
84,747
-525
-0.6% -$778 ﹤0.01% 5030
2024
Q4
$153K Sell
85,272
-7,100
-8% -$13.2K ﹤0.01% 4890
2024
Q3
$196K Buy
92,372
+585
+0.6% +$1.27K ﹤0.01% 4730
2024
Q2
$172K Buy
91,787
+10,440
+13% +$27.4K ﹤0.01% 4616
2024
Q1
$216K Buy
81,347
+9,160
+13% +$25.3K ﹤0.01% 4456
2023
Q4
$222K Buy
72,187
+8,530
+13% +$20.2K ﹤0.01% 4316
2023
Q3
$101K Buy
63,657
+49,650
+354% +$97K ﹤0.01% 4412
2023
Q2
$27.6K Buy
14,007
+1,650
+13% +$3.16K ﹤0.01% 4487
2023
Q1
$23.8K Buy
+12,357
New +$30.9K ﹤0.01% 4390
2021
Q1
Sell
-16,251
Closed -$440K 4092
2020
Q4
$440K Buy
+16,251
New +$365K ﹤0.01% 2867

Other funds holding CLLS

LPL Financial's CLLS Position: Q2 2026 in Review

LPL Financial increased its Cellectis (CLLS) stake by 0.08% in Q2 2026, buying an estimated $249 and bringing the position to 84,415 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #5586.

LPL Financial first reported a position in CLLS in Q4 2020 and has held it in 15 quarters since. The position peaked at $440K in Q4 2020. 26 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • LPL Financial held 84,415 shares of Cellectis worth $253K as of Q2 2026.
  • LPL Financial bought 70 Cellectis shares in Q2 2026, an estimated $249.
  • Cellectis made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5586 holding.
  • LPL Financial first reported a position in Cellectis in Q4 2020 and has held it in 15 quarters since.
  • LPL Financial's Cellectis position peaked at $440K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.